1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Lumiera Health Inc.

Lumiera Health Inc.

NHPHF
Lumiera Health Inc.US flagOther OTC
0.02
USD
- -
- -
3.03MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
0.01
0.01
0.01
- -
- -
- -
Basic EPS, GAAP
- -
-0.15
-0.25
-0.02
- -
-0.01
-0.04
-0.03
-0.03
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
-0.1
-0.07
-0.09
- -
-0.01
-0.02
-0.01
-0.01
-0.02
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.24
-0.5
-0.27
- -
-0.1
0.02
-0.01
-0.01
-0.01
- -
- -
Tangible Book Value per Share
- -
0.17
-0.09
0.03
- -
0.02
0.02
-0.01
-0.02
- -
- -
- -
Basic Weighted Avg Shares
- -
1
1
3
- -
8
42
63
66
122
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
1
- -
1
1
1
- -
Operating Margin (%)
- -
- -
- -
- -
-160.64
- -
-86.58
-305.11
-221.82
-351.93
-221.62
-126.68
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
-1
-2
-2
-1
-3
-2
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-170.93
- -
-274.7
-345.9
-382.54
-223.62
-439.28
-398.18
Working Capital
- -
- -
- -
- -
- -
- -
1
-1
-1
1
-2
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
1
1
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
1
- -
- -
1
-2
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Feb'23
May'23
Aug'23
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
170
170
170
Market Capitalization
4
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Feb'23
May'23
Aug'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
2
Payables & Accruals
- -
- -
- -
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-128.69%
-203.05%
-440.12%
Free Cash Flow
- -
306.37%
-50.89%
Net Income, GAAP
- -
421.32%
130.21%
Sales/Revenue/Turnover
- -
59.59%
17.19%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
1
2022
- -
- -
- -
- -
1
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.01
0.01
- -
- -
-0.01
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Mario Paradis CA, CPA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
4500, Boul. Kimber Saint-Hubert QC Canada J3Y 8K5
IPO Date
Oct 20, 2021
Website
lumiera.ca
Similar Companies
Fertil-A-Chron, Inc. (FEKR)
China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS)
Celltrion Pharm Inc (068760.KS)
Ipca Laboratories Limited (IPCALAB.NS)
4Front Ventures Corp. (FFNTF)
Organogenesis Holdings Inc. (ORGO)
Business
Lumiera Health Inc., along with its divisions, specializes in creating and bringing to market natural health and wellness items, primarily within Canada and expanding into the United States. The company provides a range of orally consumed and topical botanical formulations designed to support various health requirements. These offerings include comprehensive solutions for better sleep and managing discomfort. Through its Holizen Laboratories division, the firm offers a diverse selection of herbal tonics and nutritional supplements aimed at areas such as cardiovascular wellness, stress reduction, bone, joint, and muscle function, as well as energy and immune system support. Furthermore, Lumiera features sleep aid products under the Bazzzics brand and introduces Awaye, a distinct topical cream for pain relief that interacts with the body's endocannabinoid system without cannabis compounds. Lumiera Health Inc. maintains its main office in Saint-Hubert, Quebec, Canada.